New investments for Xpan Inc. and Nanology Labs

FACIT, a commercialization venture firm which funds Ontario oncology innovations, has announced new follow-on investments for two Toronto start-ups - Xpan Inc. and Nanology Labs. Both companies have previously received funding through FACIT’s proof-of-concept Prospects Fund.

Nanology labs.png
Xpan.png
Previous
Previous

KITE Power Play Pitch Competition

Next
Next

VoxNeuro Announces Research Project with St. Joseph's Healthcare Hamilton